If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hisanori Nishio is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Mucocutaneous Lymph Node Syndrome Medicine & Life Sciences
Arteritis Medicine & Life Sciences
Epstein-Barr Virus Infections Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Calcitonin Medicine & Life Sciences
Central Nervous System Bacterial Infections Medicine & Life Sciences
Human Herpesvirus 4 Medicine & Life Sciences
Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2018

  • 397 Citations
  • 11 h-Index
  • 26 Article
  • 1 Review article
1 Citation (Scopus)

Streptococcus pyogenes-purpura fulminans as an invasive form of group A streptococcal infection

Okuzono, S., ishimura, M., Kanno, S., Sonoda, M., Kaku, N., Motomura, Y., Nishio, H., Oba, U., Hanada, M., Fukushi, J-I., Urata, M., Kang, D., Takada, H. & Ohga, S., Jul 9 2018, In : Annals of Clinical Microbiology and Antimicrobials. 17, 1, 31.

Research output: Contribution to journalArticle

Purpura Fulminans
Streptococcal Infections
Streptococcus pyogenes
Pediatrics
Lethargy

A childhood-onset intestinal toxemia botulism during chemotherapy for relapsed acute leukemia

Ohyama, N., Torio, M., Nakashima, K., Koga, Y., Kanno, S., Nishio, H., Nishiyama, K., Sasazuki, M., Kato, H., Asakura, H., Akamine, S., Sanefuji, M., Ishizaki, Y., Sakai, Y. & Ohga, S., Sep 18 2017, In : Annals of Clinical Microbiology and Antimicrobials. 16, 1, 61.

Research output: Contribution to journalArticle

Toxemia
Botulism
Leukemia
Drug Therapy
Type A Botulinum Toxins
1 Citation (Scopus)

Calcineurin inhibitors exacerbate coronary arteritis via the MyD88 signalling pathway in a murine model of Kawasaki disease

Murata, K., Motomura, Y., Tanaka, T., Kanno, S., Yano, T., Onimaru, M., Shimoyama, A., Nishio, H., Sakai, Y., Ohora, M., Hara, H., Fukase, K., Takada, H., Masuda, S., Ohga, S., Yamasaki, S. & Hara, T., Oct 1 2017, In : Clinical and Experimental Immunology. 190, 1, p. 54-67 14 p.

Research output: Contribution to journalArticle

Arteritis
Mucocutaneous Lymph Node Syndrome
Blood Vessels
Severe Combined Immunodeficiency
Coronary Vessels

Clarithromycin plus intravenous immunoglobulin therapy can reduce the relapse rate of Kawasaki disease: A phase 2, open-label, randomized control study

Nanishi, E., Nishio, H., Takada, H., Yamamura, K., Fukazawa, M., Furuno, K., Mizuno, Y., Saigo, K., Kadoya, R., Ohbuchi, N., Onoe, Y., Yamashita, H., Nakayama, H., Hara, T., Ohno, T., Takahashi, Y., Hatae, K., Harada, T., Shimose, T., Kishimoto, J. & 2 others, Ohga, S. & Hara, T., Jul 1 2017, In : Journal of the American Heart Association. 6, 7, e005370.

Research output: Contribution to journalArticle

Mucocutaneous Lymph Node Syndrome
Passive Immunization
Clarithromycin
Intravenous Immunoglobulins
Recurrence
1 Citation (Scopus)

Clinical efficacy of cycling empirical antibiotic therapy for febrile neutropenia in pediatric cancer patients

Teranishi, H., Koga, Y., Nishio, H., Kato, W., Ono, H., Kanno, S., Nakashima, K. & Takada, H., Jul 1 2017, In : Journal of Infection and Chemotherapy. 23, 7, p. 463-467 5 p.

Research output: Contribution to journalArticle

Febrile Neutropenia
Pediatrics
Anti-Bacterial Agents
Neoplasms
Therapeutics